• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染:全面综述。

Clostridium difficile infection: a comprehensive review.

机构信息

Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital Oxford, UK, OX3 9DU.

出版信息

Crit Rev Microbiol. 2011 Aug;37(3):178-87. doi: 10.3109/1040841X.2011.556598. Epub 2011 May 24.

DOI:10.3109/1040841X.2011.556598
PMID:21609252
Abstract

Clostridium difficile is one of the most important causes of healthcare acquired diarrhea. The disease spectrum caused by C. difficile infection ranges from mild, self-limited, illness to a severe, life-threatening colitis. The incidence of C. difficile associated disease has risen dramatically over the last decade, leading to increased research interest aiming at the discovery of new virulence factors and the development of new treatment and prevention regimens. This review summarizes the pathogenesis and changing epidemiology of C. difficile associated disease, the clinical spectrum and laboratory methods to diagnose C. difficile infection, and current treatment strategies.

摘要

艰难梭菌是引起医源性腹泻的最重要原因之一。艰难梭菌感染引起的疾病谱范围从轻度、自限性疾病到严重的、危及生命的结肠炎。过去十年中,艰难梭菌相关疾病的发病率急剧上升,这导致人们对发现新的毒力因子和开发新的治疗和预防方案产生了浓厚的研究兴趣。这篇综述总结了艰难梭菌相关疾病的发病机制和不断变化的流行病学、艰难梭菌感染的临床谱和实验室方法以及当前的治疗策略。

相似文献

1
Clostridium difficile infection: a comprehensive review.艰难梭菌感染:全面综述。
Crit Rev Microbiol. 2011 Aug;37(3):178-87. doi: 10.3109/1040841X.2011.556598. Epub 2011 May 24.
2
The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.艰难梭菌感染在住院和门诊环境中的发病率和严重程度不断增加。
Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):409-16. doi: 10.1586/egh.10.48.
3
Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.癌症患者和造血干细胞移植受者中的艰难梭菌感染。
Expert Rev Anti Infect Ther. 2010 Oct;8(10):1113-9. doi: 10.1586/eri.10.95.
4
[Clostridium difficile:an epidemic event in service of public health].艰难梭菌:一次服务于公共卫生的流行事件
Rev Med Suisse. 2006 Sep 13;2(78):2071.
5
Clostridium difficile-associated diarrhoea.艰难梭菌相关性腹泻
Intern Med J. 2007 Aug;37(8):561-8. doi: 10.1111/j.1445-5994.2007.01403.x.
6
New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.艰难梭菌感染的新进展:不断变化的流行病学、诊断、治疗与控制
Curr Opin Infect Dis. 2008 Oct;21(5):500-7. doi: 10.1097/QCO.0b013e32830f9397.
7
[Epidemiology of Clostridium difficile infection].艰难梭菌感染的流行病学
Przegl Epidemiol. 2002;56(1):49-56.
8
Clostridium difficile colitis.艰难梭菌结肠炎
Surg Clin North Am. 2009 Apr;89(2):483-500, x. doi: 10.1016/j.suc.2008.09.014.
9
Clostridium difficile in children: colonisation and disease.儿童艰难梭菌:定植与疾病。
J Infect. 2011 Aug;63(2):105-13. doi: 10.1016/j.jinf.2011.05.016. Epub 2011 Jun 12.
10
Clostridium difficile enteritis: a review and pooled analysis of the cases.艰难梭菌性肠炎:病例回顾和汇总分析。
Anaerobe. 2011 Apr;17(2):52-5. doi: 10.1016/j.anaerobe.2011.02.002. Epub 2011 Feb 18.

引用本文的文献

1
Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities.解读医疗机构中抗生素暴露患者艰难梭菌感染相对风险的潜在机制的重要性。
PLoS One. 2024 Aug 8;19(8):e0306622. doi: 10.1371/journal.pone.0306622. eCollection 2024.
2
Exploring the Toxin-Mediated Mechanisms in Infection.探索感染中毒素介导的机制。
Microorganisms. 2024 May 16;12(5):1004. doi: 10.3390/microorganisms12051004.
3
Design, Synthesis and Biological Evaluation of Novel PEG-Rakicidin B1 Hybrid as (CD) Targeted Anti-Bacterial Agent.
设计、合成及新型 PEG-瑞卡丁 B1 杂合体的生物学评价作为 (CD) 靶向抗菌剂。
Molecules. 2023 Aug 21;28(16):6152. doi: 10.3390/molecules28166152.
4
Frequency of Diarrhea, Stool Specimen Collection and Testing, and Detection of Clostridioides Difficile Infection Among Hospitalized Adults in the Muenster/Coesfeld Area, Germany.德国明斯特/科菲尔德地区住院成人的腹泻频率、粪便标本采集和检测以及艰难梭菌感染的检出率。
Curr Microbiol. 2022 Dec 16;80(1):37. doi: 10.1007/s00284-022-03143-6.
5
To study the contributing factors and outcomes of Clostridioides difficile infection in patients with solid tumors.研究实体瘤患者艰难梭菌感染的促成因素及结局。
Heliyon. 2021 Nov 26;7(12):e08450. doi: 10.1016/j.heliyon.2021.e08450. eCollection 2021 Dec.
6
Strain T21 Attenuates Infection in a Murine Model Through Reduction of Inflammation and Gut Dysbiosis With Decreased Toxin Lethality and Enhanced Mucin Production.菌株T21通过减轻炎症和肠道生态失调、降低毒素致死率以及增强粘蛋白生成来减轻小鼠模型中的感染。
Front Microbiol. 2021 Dec 1;12:745299. doi: 10.3389/fmicb.2021.745299. eCollection 2021.
7
Bovine Colostrum and Its Potential for Human Health and Nutrition.牛初乳及其对人类健康和营养的潜在作用。
Front Nutr. 2021 Jun 21;8:651721. doi: 10.3389/fnut.2021.651721. eCollection 2021.
8
Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.比较急性医疗机构中降低艰难梭菌传播的干预策略:基于代理的建模研究。
BMC Infect Dis. 2020 Oct 28;20(1):799. doi: 10.1186/s12879-020-05501-w.
9
Ultrapotent Inhibitor of Growth, Which Suppresses Recurrence .超强生长抑制剂,抑制复发。
J Med Chem. 2020 Oct 22;63(20):11934-11944. doi: 10.1021/acs.jmedchem.0c01198. Epub 2020 Oct 6.
10
Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship.肠道微生物群调节:对感染控制和抗菌药物管理的影响。
Adv Ther. 2020 Oct;37(10):4054-4067. doi: 10.1007/s12325-020-01458-z. Epub 2020 Aug 7.